Lecture 35: Addiction Flashcards

1
Q

what is a drug?

A

WHO definition of drug:
- a chemical entity used non-medically, self-administered for its psychoactive effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are some examples of drugs?

A
  • CNS depressants: alcohol, benzodiazepines and barbiturates
  • CNS stimulants: smphetamines, MDMA, BZP
  • Opiods: oxycodone, morphine, codeine, methadone, homebake
  • Hallucinogens: LSD, psiloycybin, ketamine
  • cannabinods
  • solvents
  • others: steroids, nicotine, caffeine, anticholinergics, antihistamines etc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

define tolerance?

A
  • reduction in response to a drug after repeated administration
  • due to receptor/second messenger desensitisation/downregulation
  • acute vs chronic tolerance
  • may lead to increaed intake to get desired effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

define dependence?

A
  • compulsive drug-taking behaviour; loss of ability to control use; intrusion into normal activities; + tolerance + withdrawal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

define withdrawal?

A
  • rebound physiological effects upon cessation or reduction of drug intake
  • symptoms usually opposite to those produced by drug (e.g. insomnia, anxiety - BDZs, alcohol; sedation, depression - cocaine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what factors are associated with substance dependence?

A
  • environmental factors
  • host factors
  • drug factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are environmental factors associated with substance abuse?

A
  • family or peer group behaviour
  • availability of other reinforcers (e.g. recreational resources)
  • job/educational opportunities
  • conditioned stimuli (environmental cues paired with drug use)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are host factors associated with substance dependence?

A

Gene:

  • positive and negative for alcohol (defective ALDH genes in Asians; reduced sensitivity to alcohol phenotype in alcoholics);
  • opiod dependence associated with 2 sites of chromosome 17
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is used to predict teenage binge drinking?

A

the prediction model

  • prediction of binge drinking based on data from a longitudinal study (IMAGEN) in 692 adolescents
  • main model components:
    History (romantic, sexual relationship, smoking, prior deviant behaviour etc)
    Personality (extravagence, excitability, disorganisation)
    Brain (pharenchymal (grey matter) volume)
  • the odds of adult alcohol dependence are reduced by 10% for each year drinking onset is delayed in adolescence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are drug factors associated with substance dependence?

A
  • ease of drug availability, price, purity and potency
  • how it is administered (GI, intranasal, IV, inhalation)
  • pharmacokinetic profile (speed of onset and offset of effects)
    diagram: IV dosing, smoking and snorting is rapidly aborbed and high climax with intense eurphoria and psychological effects, while oral dosing (e.g. methadone) is slowly absorbed with lower climax with lower intensity psychological effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the pharmalogical mechanism for drugs of abuse/dependence?

why do some drugs feel better than others?

A

dopamine release in the nucleus accubens

dependence-inducing drugs have many different pharmacologies
e.g. alcohol - GABA-A;GIRKS, Opioids - µ-opioid receptors, Nicotine - α4β2-nicotinic cholingeric receptors, Cocaine - DA transporter etc

BUT all release dopamine in the nucleus accumbens

associated with positive, rewarding and euphoric feelings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

is it possible to treat addiction by blocking central reward pathways?

A
  • a study done on 11 cocaine-dependent subjects
  • rising, single dose, placebo insertion design. Placebo and 3 ecopipam doses (10,25 and 100mg) given.
  • cocaine 30mg IV given 2h after ecopipam/placebo dosing.
  • cocaine subjective effects measured by visual analog scales; also blood pressure and heart rate

results:

  • 10mg didn’t have much of an effect
  • 100mg blocked 80-90% of dopamine receptors

After 5-10 mins of the placebo, participants reported feeling high. wears off after 30mins

Ecopipam produced dose-dependent reductions in subjective effects of cocaine. CV effects of cocaine (BP,HR) were not affected

but chronic dosinhg = rapid tolerance occurs to antagonist effects

so only a single dose of ecopipam can treat addiction :(

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how is a substance use disorder determined?

A

(DSM-V)

11 criteria covering 4 areas, over 12 months

2-3 months criteria = mild substance use disorder,
4-5months = moderate substance use disorder
≥6 months = severe

  • *1. Impaired control**
    1. taking more or for longer than intended
    2. unsuccessful efforts to stop or cut down use
    3. spending a great deal of time obtaining, using, or recovering from use
    4. craving for substance
  • *2. Social Impairment**
    5. failure to fulfil major obligations due to use
    6. continued use despite problems caused or exacerbated by use
    7. important activities given up or reduced because of substance abuse
  • *3. Risky use**
    8. recurrent use in hazardous situations
    9. continued use despite physical or psychological problems that are caused or exacerbated by substance use
  • *4. Pharmacologic dependence**
    10. tolerance to effects of the substance
    11. withdrawal symptoms when not using or using less
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the trends of using substances globally?

A
  • according to WHO (and despite war on drugs)
  • increase use of illicit substances
  • lower age of initiation
  • growth in world supply
  • use of multiple substances
  • increasing levels of intoxication, alcoholic poisoning and drug ODs
  • increased use by women
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how are the prevalence rates of drugs used in NZ?

A

Community Samples

  • Adolescent Health Research Group (2003)
  • Illicit Drug Monitoring System (IDMS) - Massey U

Longitudinal Research

  • Christchurch Health and Development Study
  • Dunedin Multidisciplinary Health and Development Study

Clinical Samples

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what does this show?

A

12 month prevalence data - NZ Mental Health Survey 2006

  • most overrepresented are young adults 16-24 year olds (7.1% alcohol abuse, 3% alcohol dependence, 3.8% drug abuse, 2.1% drug dependence)
  • with age, the prevalence of drug and alcohol use decreases

males are more affected than females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what does this show?

A

IDMS (illicit drug monitoring system) overview of trends in drug use in the past six months for 2014 in NZ

some drugs are easy to access, some prices are decreasing or stable, number of users in increasing,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what does this show?

A

ease and time taken to buy methamphetamine and cannabis in NZ

each province found it was easier to buy methamphetamine than cannabis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what are the acute harms of cannabis?

A
  • adverse reactions to intoxication
  • drinking whilst introxicated
    cannabis use impairs aspects of cognitive performance (e.g. manual dexterity, attention in continuous performance tasks; use before driving probably increases the risk of a traffic crash. estimates of 2.5% for MVA deaths vs alcohol 29%
  • Pregnancy are pre-natal cannabis exposure
  • decreased cognitive performance at age 3 years and behavioural problems at age 10 years
20
Q

what are the chronic harms of cannabis?

A
  • dependence
  • respiratory and cardiovascular impairment
    probable impaired respiratory function and increase in cancers
  • psychosocial functioning
    ChCh birth cohort -cannabis use at 14-25y associated with poorer educational outcomes, lower income, greater welfare dependence and unemployment and lower relationship and life satisfaction.
  • Mental health
    modest association with schizophrenia psychosis

OR of psychosis and lifetime cannabis use = 1.27
OR of psychosis and lifetime cannabis abuse = 1.79
OR of psychosis and lifetime cannabis dependence = 3.69

21
Q

what was found in the study investigating cannabis and harm to health in adolescents?

A
  • Silins, Lancet Psychiatry 2014
  • prospective psychosocial outcomes in ~3000NZ/Australian adolescents followed to age 30
  • Those with daily use of cannabis before age 17 were
    60% less likely to complete high school and 60% less likely to attain a university degree qualification. 18 time more likely to become cannabis dependent. 8 time more likely to use other illicit drugs. ~7 times more likely to attempt suicide
22
Q

what are synthetic cannabinoids?

A
  • chemicals that bind to cannabinoid CB1 and CB2 receptors
  • they mimic the effect of THB
  • however, most of them are full agonists with a much greater potency than THC (THC is 50% agonist)
  • studies were published for medicinal use for synthetic cannabis
  • this lead tom many hundreds being synthesised
  • increasing use since 2007.
23
Q

what are the most commonly reported synthetic cannabis toxicities?

A
  • tachycardia (30.2% of all reported cases)
  • agitation (13.5%)
  • drowsiness (12.3%)
  • nausea/vomiting (8.2%)
  • hallucination (7.6%)
  • death or serious medical complications were uncommon (<1%) up to 2016 in the local/international literature, however in NZ recently there have been >75 deaths associated with the use of AMB-Fubinaca and AB-Pinaca (synthetic cannabis)
24
Q

what are the harms of large alcohol consumption?

A
25
Q

what are the harms of small to moderate consumption?

A
26
Q

what are the effects linked with small and large consumption?

A
27
Q

what did the alcohol and harm in NZ study investigate?

A
  • a postal survey of ~2000 randomly selected adults (18-80y) representative of NZ population

Assessed alcohol intake, problems and harms due to drinking:

  • drinking related harms: self-assessed personal problems resulting from drinking
  • drinking related troubles: various legal and social problems
28
Q

what were the findings of the alcohol and harm in NZ study?

A
  • Males were ~twice as likely than females to have a heavy drinking episode, report any harm and any trouble
  • Higher reports of heavy drinking episode, any harm and any trouble in young adults which decreases with age
  • lowest rates in asian ethnicites, highest rates in maori ethnicities, and european ethnicities in the middle
29
Q

what is the relative harm assessment?

A
  • a multicriteria decision analysis modelling of a range of drug harms, for drugs commonly available in the UK, via an expert commitee
30
Q

what were the findings of the relative harm assessment?

A
  • alcohol is most harmful for others, and 4th harmful for users
  • cannabis is quite low harm for others and users
31
Q

what does this show?

A

this is a bar graph form of the previous graph.

  • alcohol was most harmful overall
  • heroin and crack were next
  • tobacco and cannabis were roughly the same harm overall (26 and 20)
32
Q

what has been found about scheduling and harm liability?

A

there is no clear relationship between scheduling and harm liability

  • law/drug scheduling is not based on science - it is driven by social and political decisions and safety is not considered
  • There is a historical perpective to it as well. If alcohol had just been discovered, would it be approved for sale?
33
Q

how much regulation is needed for cannabis and synthetic cannabis?

A

Cannabis: decriminalisation is increasingly common overseas (but the 2019 cannabis referendum was negative in NZ)

Synthetic cannabis:
in June 2013, there was the Psychoactive Substances Act. Psychoactive Substances Regulatory established (within Medsafe); products must meet adequate safety requirements

In August 2013, 50 ahopa approved by MoH to sell 28 brands of legal highs

  • they were only available from R18 shops with labelling less appealing to minors. Interim approval - MoH was still devising permanent licensing regine
  • EPS/ED visits dropped 50%; same patient group with same presenting symptoms

May 2014: All products withdrawn; future of legislation is inclear

34
Q

how much regulation is needed for alcohol?

A

a middle ground needs to be found between excessive commercialisation of alcohol and prohibition of alcohol

35
Q

what are the benefits of prohibition and costs of prohibition?

A

Benefits:

  • does it lessen use?
  • does it lessen use of other drugs? (gateway hypothesis)
  • gives a message to society of danger use
  • ftis with international treaties

Costs:

  • Probition does not deter use
  • it is resource intensive
  • black market, gangs, access to other drugs
  • No quality control - variations in drug content, quality
  • lost tax revenue
  • discriminatory and variable application of the law
  • misleading health info as grouped with ‘hard drugs’
36
Q

what are the three pillars to maintain national alcohol situation?

A
  1. An immensely powerful global alcohol industry
  2. Political pragmatism of governments
  3. The idea that it is individual drinkers who are casuing the problem - not a population level problem
37
Q

how does marketing and advertising impact alcohol use?

A

NZ spends >$200,000 per day on advertising and marketing

It normalises and maintains a heavy drinking culture in NZ

38
Q

what is the 5+ solution for alcohol?

A
  1. Raise alcohol prices
  2. Raise the purchase age
  3. Reduce alcohol accessibility
  4. Reduce marketing and advertising
  5. Increase drink-driving counter-measures
    PLUS: Increase treatment opportunities for heavy drinkers
39
Q

what is the relationship between price and how much alcohol is consumed?

A

data from london

Price of alcohol has gone down and consumption has gone up!

40
Q

does altering the price and availability of alcohol affect the consumption and harm of it?

A

Denmark increased tax, had -76% consumption, DTs cases -93% and alcohol deaths -83%

Russia reduced availability, -34% consumption, alcohol deaths -54%

Sweden had abolition of alcohol rationing (easier to access), +25% consumption, +438% DTs cases

Finland made beer available in grocery stores (20x availability), +46% consumption, alcohol deaths +58%

these trends show that limiting access decreases consumption and harm

41
Q

what are the treatment options for dependence (withdrawal symptoms)?

A
  • Acute detox (hospital/community)
  • CADS (community alcohol and drugs service)
  • NA/AA; Alanon for family/friends/spouses
  • Community organisations (bridge programme; odyssey house; others)
  • most benefit from psychological/social approaches, medication has only a small role
42
Q

what are the drug treatment options for drug/alcohol dependence?

A

substitution treatment, anti-craving medication, antagonist/aversive medication

43
Q

what is substitution treatment?

A
  • methadone, buprenorphine for opioid dependence
  • nicotine, varenicline for smoking
44
Q

what are anti-craving medications?

A
  • Naltrexone (acamprostate) for alcohol dependence
  • Buproprion for smoking
45
Q

what are antagonist/aversive medication?

A
  • Naltrexone for opioid dependence (not licensed in NZ)
  • disulfiram for alcohol dependence
46
Q

what is the future like for addiction?

A
  • local research
  • abnormal salience (craving) for alcohol via increased anterior cingulate activity
  • stimulation via implane associated with reduced craving and alcohol consumption
  • an electrode is placed between 2 halves of the brain which sends electrical burst signals and the correct frequency can shut off that craving.
  • graph shows: People who were taking 25 standard drinks per day on baseline, went to 0-5 standard drinks after 4-24 weeks.